Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247658526> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4247658526 endingPage "937" @default.
- W4247658526 startingPage "927" @default.
- W4247658526 abstract "The contribution of von Willebrand factor (vWF)-platelet binding to platelet-collagen interaction was examined in vitro. The binding of vWF to platelets was mediated and regulated by ristocetin. Subthreshold concentrations of ristocetin (less than or equal to 1 mg/mL), insufficient to cause ristocetin-induced platelet aggregation (RIPA), were added to platelet-rich plasma (PRP) prior to the addition of collagen. The collagen-induced platelet aggregation (CIPA) was modified by ristocetin and the degree of alteration was dependent on the ristocetin concentration. Response as a function of ristocetin concentration was designated the Collagen-Platelet Aggregation Response (CoI-PAR). In normal PRP the CoI-PAR was a progressive inhibition followed by decreasing inhibition and then an enhanced response. The enhanced response occurred over a narrow range of ristocetin concentrations (0.8 to 1.0 mg/mL). In the absence of vWF (severe von Willebrand's disease, Type I, vWF less than 1%) the CoI-PAR was a progressive, eventually complete inhibition with no enhanced response (with ristocetin concentrations up to 3.0 mg/mL). With addition of vWF to this PRP an enhanced response was observed at a ristocetin concentration inversely proportional to the vWF level. PRP from a patient with severe Hemophilia A showed a response within the normal range. Subthreshold ristocetin did not cause plasma protein precipitation or platelet release of 3H-serotonin, nor induce micro platelet aggregate formation. Digestion of platelet membrane glycoproteins (GP(s] with chymotrypsin demonstrated that upon removal of GPI, RIPA was absent, CIPA retained and the CoI-PAR was progressive inhibition, with no enhancement. With removal of GPs I, II, and III, RIPA, CIPA, and the CoI-PAR were absent. A dose-response 125I-vWF- platelet binding occurred with increasing ristocetin concentrations which was unchanged by the addition of collagen. These results demonstrated that ristocetin-platelet association inhibited CIPA, and vWF-platelet binding enhanced platelet-collagen adhesion and platelet aggregation. The in vitro-enhanced CIPA represents a vWF-dependent aggregation of sufficient magnitude to overcome the inhibitory effect of ristocetin. These studies demonstrate an influential interaction of ristocetin, vWF, and collagen with the platelet membrane and imply an important hemostatic contribution of vWF-platelet binding in platelet- collagen interaction." @default.
- W4247658526 created "2022-05-12" @default.
- W4247658526 creator A5018224569 @default.
- W4247658526 creator A5040923345 @default.
- W4247658526 creator A5062287004 @default.
- W4247658526 creator A5068394851 @default.
- W4247658526 date "1986-10-01" @default.
- W4247658526 modified "2023-10-04" @default.
- W4247658526 title "Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding" @default.
- W4247658526 doi "https://doi.org/10.1182/blood.v68.4.927.bloodjournal684927" @default.
- W4247658526 hasPublicationYear "1986" @default.
- W4247658526 type Work @default.
- W4247658526 citedByCount "0" @default.
- W4247658526 crossrefType "journal-article" @default.
- W4247658526 hasAuthorship W4247658526A5018224569 @default.
- W4247658526 hasAuthorship W4247658526A5040923345 @default.
- W4247658526 hasAuthorship W4247658526A5062287004 @default.
- W4247658526 hasAuthorship W4247658526A5068394851 @default.
- W4247658526 hasBestOaLocation W42476585261 @default.
- W4247658526 hasConcept C126322002 @default.
- W4247658526 hasConcept C134018914 @default.
- W4247658526 hasConcept C185592680 @default.
- W4247658526 hasConcept C26828662 @default.
- W4247658526 hasConcept C2776057759 @default.
- W4247658526 hasConcept C2779394231 @default.
- W4247658526 hasConcept C2780076745 @default.
- W4247658526 hasConcept C71924100 @default.
- W4247658526 hasConcept C86803240 @default.
- W4247658526 hasConcept C89560881 @default.
- W4247658526 hasConceptScore W4247658526C126322002 @default.
- W4247658526 hasConceptScore W4247658526C134018914 @default.
- W4247658526 hasConceptScore W4247658526C185592680 @default.
- W4247658526 hasConceptScore W4247658526C26828662 @default.
- W4247658526 hasConceptScore W4247658526C2776057759 @default.
- W4247658526 hasConceptScore W4247658526C2779394231 @default.
- W4247658526 hasConceptScore W4247658526C2780076745 @default.
- W4247658526 hasConceptScore W4247658526C71924100 @default.
- W4247658526 hasConceptScore W4247658526C86803240 @default.
- W4247658526 hasConceptScore W4247658526C89560881 @default.
- W4247658526 hasIssue "4" @default.
- W4247658526 hasLocation W42476585261 @default.
- W4247658526 hasOpenAccess W4247658526 @default.
- W4247658526 hasPrimaryLocation W42476585261 @default.
- W4247658526 hasRelatedWork W16268158 @default.
- W4247658526 hasRelatedWork W17074206 @default.
- W4247658526 hasRelatedWork W17303474 @default.
- W4247658526 hasRelatedWork W1962110 @default.
- W4247658526 hasRelatedWork W19776461 @default.
- W4247658526 hasRelatedWork W20722669 @default.
- W4247658526 hasRelatedWork W2644079 @default.
- W4247658526 hasRelatedWork W27991937 @default.
- W4247658526 hasRelatedWork W34646118 @default.
- W4247658526 hasRelatedWork W5974579 @default.
- W4247658526 hasVolume "68" @default.
- W4247658526 isParatext "false" @default.
- W4247658526 isRetracted "false" @default.
- W4247658526 workType "article" @default.